Showing posts with label Ultrasound. Show all posts
Showing posts with label Ultrasound. Show all posts

Friday, March 22, 2024

Portable Ultrasound Market to be Worth $3.8 Billion by 2031

 

Meticulous Research®—a leading global market research company, published a research report titled, ‘Portable Ultrasound Market by Product (POCUS, Handheld Ultrasound, Transducer, Gels), Technology (2D, 3D, 4D, Doppler), Display, Application (Breast Cancer, MSK, OB/GYN, CVD, Urology), End User (Hospitals, ACC, Imaging Center) – Global Forecast to 2031.’

 

Download Free Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5800?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=22-03-2024

 

According to this latest publication from Meticulous Research®, the global Portable Ultrasound Market is projected to reach $3.8 billion by 2031, at a CAGR of 7.9% during the forecast period 2024–2031. The growth of the portable ultrasound market is driven by factors such as the growing adoption of portable medical devices in emergency care settings, the proliferation of hospitals, and the increasing demand for handheld ultrasound devices in ambulatory care centers and dialysis centers.

 

The growing preference for portable ultrasound devices over standard ultrasound machines among healthcare professionals and the rising demand from emerging economies are expected to create growth opportunities for players operating in this market. However, factors such as the shortage of skilled professionals, inadequate training programs for healthcare professionals on the use of portable ultrasound devices, reimbursement irregularities, poor image quality, and integration issues of portable ultrasound devices with existing digital health infrastructure pose challenges to the market's growth.

 

Key Players

 

The key players operating in global Portable Ultrasound Market are GE Healthcare Technologies Inc. (U.S.), Siemens Healthineers AG (Germany), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Koninklijke Philips N.V., (Netherlands), Samsung Medison Co. Ltd. (A subsidiary of Samsung Electronics Co. Ltd.) (South Korea), FUJIFILM Sonosite, Inc. (A subsidiary of FUJIFILM Holdings Corporation) (U.S.), ALPINION MEDICAL SYSTEMS Co., Ltd. (South Korea), Esaote S.p.A (Italy), EDAN Instruments, Inc. (China), EchoNous, Inc. (U.S.), Butterfly Network, Inc. (U.S.), Konica Minolta, Inc. (Japan), CHISON Medical Technologies Co., Ltd (China), SonoScape Medical Corp. (China), and Healcerion Co., Ltd. (South Korea).

 

TOP 10 COMPANIES IN PORTABLE ULTRASOUND MARKET >> https://meticulousblog.org/top-10-companies-in-portable-ultrasound-market/?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=22-03-2024

 

Portable Ultrasound Market: Future Outlook

 

The global Portable Ultrasound Market is segmented by product (Devices [by Portability {Point-of-care (PoC) Ultrasound (Machines and Transducers), Handheld Ultrasound}, by Technology {2D, 3D & 4D, Doppler}, by Display {Black & White (B/W), Colored}], Gels, Accessories), Application ( OB/GYN, Cardiovascular, Urology, Musculoskeletal, Breast Cancer, Other Applications), End User (Hospitals & Clinics, Diagnostic Imaging Centers, Ambulatory Care Centers, Other End Users) and Geography. The study also evaluates industry competitors and analyzes the market at regional and country levels.

 

Based on product, the global portable ultrasound market is segmented into devices, gels, and accessories. In 2024, the devices segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the growing demand for POCUS in emergency departments, increasing preference for ultrasound imaging near patients, the growing prevalence of chronic diseases, and technological advancements in portable ultrasound devices.

 

Request Free Research Report Sample @ https://www.meticulousresearch.com/request-sample-report/cp_id=5800?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=22-03-2024

 

Based on portability, the devices segment is further sub-segmented into point-of-care (PoC) ultrasound and handheld ultrasound. The handheld ultrasound segment is expected to register a higher CAGR during the forecast period. This growth is attributed to the development and introduction of new handheld ultrasound devices tailored for specific applications, integration of artificial intelligence (AI) and machine learning, and other technological advancements.

 

Based on application, the global portable ultrasound market is segmented into OB/GYN, cardiovascular, urology, musculoskeletal, breast cancer, and other applications. In 2024, the OB/GYN segment is expected to account for the largest share of the global portable ultrasound market. The large market share of this segment can be attributed to the growing prevalence of conditions related to women’s reproductive health, reduction in global infertility rates, and high incidence & rising awareness regarding early diagnosis and monitoring of PCOD & PCOS.

 

According to data published by the WHO in 2023, Polycystic ovarian syndrome (PCOS) is characterized by an ovary with a follicle count ≥12 and a size of 2 or 3 mm3. This syndrome produces side effects related to women’s overall health, such as abnormal hair growth, weight gain, irregular menstrual cycle, infertility, and depression. Almost 70% of women with PCOS have infertility, and this condition is one of the common reasons for female infertility. PCOS occurs in women during their reproductive years, between 18 and 45 years old.

 

Browse in depth @ https://www.meticulousresearch.com/product/portable-ultrasound-market-5800?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=22-03-2024

 

Based on end user, the global portable ultrasound market is segmented into hospitals & clinics, diagnostic imaging centers, ambulatory care centers, and other end users. In 2024, the hospitals & clinics segment is expected to account for the largest share of the portable ultrasound market. The large market share of this segment is attributed to the increasing hospitalizations due to chronic diseases associated with an aging population, increasing healthcare expenditure, the adoption of advanced imaging modalities in hospitals, preference for low-cost products to control healthcare costs, rising focus on providing point-of-care/bedside service to patients, and the proliferation of healthcare facilities especially in emerging economies.

 

Portable ultrasound systems, including POCUS and handheld ultrasound, can be used near patient areas and do not require patients to visit special medical imaging centers for the diagnosis of various medical conditions. Moreover, getting a bedside medical imaging facility helps healthcare professionals in early diagnosis and treatment planning, driving the adoption of portable ultrasound in hospitals and clinics.

 

Geographic Review

 

This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, and the Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa. China is expected to register the highest CAGR during the forecast period (2024-2031). This growth can be attributed to the rising incidence of orthopedic injuries and cancer, the aging demographic, government initiatives aimed at encouraging early disease detection, the widespread adoption of advanced medical technologies, ongoing improvements in healthcare infrastructure, and increasing healthcare spending.

 

Download Free Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5800?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=22-03-2024

Tuesday, November 7, 2023

Microbubbles/Ultrasound Contrast Agents Market: Applications and End Users

 

According to a new market research report titled, ‘Microbubbles/Ultrasound Contrast Agents Market by Application (Diagnostic Imaging [Cardiovascular, Renal, Abdominal, Breast] Therapeutics) Type (Lipid, Protein, Polymer) End User (Hospitals & Clinics, Diagnostics Laboratories)- Global Forecast to 2030,’ published by Meticulous Research®, the microbubbles/ultrasound contrast agents market is projected to reach $1.95 billion by 2030, at a CAGR of 15.2% from 2023 to 2030.

Ultrasound contrast agents are gas-filled microbubbles that are used to improve the capabilities of diagnostic imaging. They play an important role in ultrasound imaging and ultrasound-mediated therapy. Microbubble contrast agents are giving new avenues for therapeutic applications of ultrasound in drug delivery, gene therapy, and thrombolysis.

Download Free Sample Report Now: https://www.meticulousresearch.com/download-sample-report/cp_id=3732

The report also includes an extensive assessment of the key strategic developments of leading market participants in the industry in the last three to four years. The global microbubbles/ultrasound contrast agents’ market has witnessed several strategic developments in recent years.

The high demand for image & diagnostics-guided procedures, the growing aging population, coupled with the rising prevalence of chronic diseases, technological advances in ultrasound imaging, and favourable reimbursement policies for contrast-enhanced procedures are driving the growth of this market. In addition, increasing microbubbles/ultrasound contrast agents-related research activities will likely offer better opportunities for market growth. However, the complexity involved in contrast-enhanced Ultrasound (CEUS) is expected to restrain the market's growth to some extent.

Aging Population Coupled with the Increasing Prevalence of Chronic Diseases to Drive the Demand for Microbubbles/Ultrasound Contrast Agents

Chronic diseases such as cardiovascular diseases, osteoarticular problems, sleep and mobility disorders, diabetes, and chronic ischemic heart disease is a major and common concern among the elderly population. They can lead to limitations in mental and physical abilities, hospitalization, and increased healthcare expenditures.

Osteoporosis is a common condition in the elderly population that can be detected using ultrasound. However, chronic diseases such as diabetes and cardiovascular disease can also affect bone health and may lead to false-positive results on ultrasound. Thus, it is important to consider the presence of chronic diseases in the elderly population when interpreting the ultrasound results.

Have Any Query? Ask To Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=3732

According to the World Population Ageing 2020 report released by the Department of Economic and Social Affairs, United Nations, globally, there were 727 million people aged 65 or above in 2020. It is estimated that by 2050 this number will reach 1.5 billion.

The aging population drives a rise in the number of people suffering from chronic diseases. Having an ultrasound near the bed is incredibly useful to older people who cannot move easily or may be anxious to travel to another setting. This increases the demand for ultrasound procedures for older adults. Ultrasound technology can be used for evaluating several disorders, such as bone health and diagnosing heart disease, which may lead to an increased demand for ultrasound in the geriatric population.

Hence, the aging population will likely increase the demand for microbubbles/ultrasound contrast agents due to growing utilization, the rising prevalence of chronic diseases, and the increased demand for healthcare services.

Microbubbles/Ultrasound Contrast Agents Market: Future Outlook

The microbubbles/ultrasound contrast agents market is segmented by type [lipid microbubbles, protein microbubbles, polymer microbubbles], application [diagnostics imaging {cardiovascular imaging, renal imaging, abdominal imaging, breast imaging, other diagnostics imaging applications}, therapeutic applications], end user (hospitals & clinics, diagnostics laboratories, other end users], and geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).           

Based on type, the microbubbles/ultrasound contrast agents’ market is segmented into lipid microbubbles, protein microbubbles, and polymer microbubbles. The lipid microbubbles segment is expected to account for the largest share of the market in 2023. Lipid-based microbubbles ultrasound imaging with contrast agents has become an essential tool in clinical diagnostics. It is applied in drug delivery systems which are the materials working for soft synthetic shells. These lipid shells offer several ways to support additional functions over increased contrast, such as minimally invasive detection of biochemical signatures. Additionally, improved ultrasound imaging technology and safety & security support the largest share of the segment.

Quick Buy – Microbubbles/Ultrasound Contrast Market- Global Opportunity Analysis and Industry Forecast (2023-2030), Research Report: https://www.meticulousresearch.com/Checkout/23012734

Based on application, the microbubbles/ultrasound contrast agents market is segmented into diagnostics imaging and therapeutic applications. Diagnostic imaging is expected to account for the largest share of the microbubbles/ultrasound contrast agents market in 2023. The large market share of this segment is attributed to the technological developments in specialized application modalities, increasing awareness among people regarding early diagnosis, and the rising prevalence of chronic diseases, including cardiovascular diseases such as heart failure and coronary artery disease are the major causes of premature death every year. For instance, according to the Centers for Disease Control and Prevention, in 2020, about 523 million people had some form of cardiovascular disease and nearly 19 million deaths were caused globally.

Based on end user, in 2023, the hospitals & clinics segment is expected to account for the largest share of the microbubbles/ultrasound contrast agents market. People prefer visiting hospitals for treatment as hospitals or clinics have well-established infrastructure. Most people regained the accessibility of healthcare facilities and started visiting hospitals for routine checkups or testing, contributing to the large market share of the segment.

Based on geography, the microbubbles/ultrasound contrast agents market is segmented into North America, Europe, Asia-pacific, Latin America, and Middle East & Africa. In 2023, North America is expected to account for the largest share of the microbubbles/ultrasound contrast agents market. The large market share of this segment is primarily due to the aging population and increasing prevalence of chronic diseases, advanced healthcare systems in the U.S. and Canada, accelerated growth of economies and high adoption of advanced technologies.

Some of the key players operating in the microbubbles/ultrasound contrast agents market are Lantheus Holdings, Inc. (U.S.), GE HealthCare Technologies Inc. (U.S.), Bracco S.p.A. (Italy), Bristol-Myers Squibb Company (U.S.), Daiichi Sankyo Company, Limited (Japan), nanoPET Pharma GmbH (Germany), Leriva (Greece), Siemens Healthineers AG (Germany), Bayer AG (Germany), and Fujifilm Holdings Corporation (Japan).

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/microbubbles-ultrasound-contrast-agents-market-3732

Scope of the Report:

Microbubbles/Ultrasound Contrast Agents Market Assessment - by Type

  • Lipid Microbubbles
  • Protein Microbubbles
  • Polymer Microbubbles

Microbubbles/Ultrasound Contrast Agents Market Assessment - by Application

  • Diagnostics Imaging
    • Cardiovascular Imaging
    • Renal Imaging
    • Abdominal Imaging
    • Breast Imaging
    • Other Diagnostics Imaging Applications
  • Therapeutics Applications

(Note: Other diagnostics imaging applications include cancer and ocular)

Request Free Sample Report Now: https://www.meticulousresearch.com/request-sample-report/cp_id=3732

 

Microbubbles/Ultrasound Contrast Agents Market Assessment - by End User

  • Hospitals & Clinics
  • Diagnostics Laboratories
  • Other End Users

(Note: Other end users include pharmaceutical & biotech companies, research & academic institutes, and government laboratories)
Microbubbles/Ultrasound Contrast Agents Market Assessment- by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

 

TOP 10 COMPANIES IN MICROBUBBLES/ULTRASOUND CONTRAST AGENTS MARKET @  https://meticulousblog.org/top-10-companies-in-microbubbles-ultrasound-contrast-agents-market/?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=07-11-2023

Monday, May 25, 2020

NON INVASIVE PRENATAL TESTING (NIPT) MARKET GLOBAL OPPORTUNITY ANALYSIS AND INDUSTRY FORECAST (2019 – 2027)

Meticulous Research®– leading global market research company published a research report titled “Non Invasive Prenatal Testing (NIPT) Market by Product & Solution (Consumables, Systems, Software), Method (Ultrasound Screening, Cell Free DNA Test), Application (Trisomy, Microdeletions, Monosomy), and End-user (Diagnostic Labs) – Global Forecast to 2027”. 
The high growth of non-invasive prenatal testing market is mainly attributed to the high risk of chromosomal abnormalities with increasing maternal age, rise in occurrences of chromosomal aneuploidies among fetus, development of advanced and new technologies and non-invasive parenteral testing products, and improving reimbursement scenario for NIPT. In addition, rising awareness regarding non-invasive prenatal testing and untapped market opportunity in emerging markets offer significant growth opportunities for the players operating in this market.
Non-Invasive Prenatal Testing (NIPT), a novel genetic screening method based on the analysis of cell-free deoxyribose nucleic acid (cf-DNA) of the fetus in the maternal plasma is considered as a valuable test for the pregnant women to provide early diagnosis of genetic disorders. NIPT offers several advantages over conventional prenatal testing procedures; in addition to being non-invasive, these tests offer shorter turnaround times, lower risk to fetus and pregnant women during testing, and high accuracy. Increasing occurrences of chromosomal aneuploidies among fetus with the increase in maternal age, availability of the partial reimbursement policies for NIPT services in some of the countries, and developments in new technologies are the key factors driving steady growth in the global NIPT market.
Request Free Sample Report to get the short-term and long-term impact of COVID-19 on this Market https://www.meticulousresearch.com/request-sample-report/cp_id=5068
PNG-Non-Invasive-Prenatal-Testing-(NIPT)-Market---1
The global non-invasive prenatal testing market study presents historical market data in terms of values (2017 and 2018), estimated current data (2019), and forecasts for 2027- by product & solution (consumables, systems, software), method (ultrasound screening, cell free DNA test), application (trisomy, microdeletions, monosomy), and end-user. The study also evaluates industry competitors and analyzes the market at regional and country level.
Click here to get the short-term and long-term impact of COVID-19 on this Market. https://www.meticulousresearch.com/enquire-before-buying/cp_id=5068
On the basis of products and solutions, the kits/consumables segment commanded the largest share of the overall NIPT market in 2019, mainly due to increasing incidences of chromosomal abnormalities, rise in the number of tests and products for NIPT, and improvement of approvals or licenses for assays.
On the basis of application, trisomy segment accounted for the largest share of the overall NIPT market in 2019. The large share of this segment is mainly attributed to the factors such as the increasing maternal age and rising incidence of chromosomal abnormalities.
On the basis of end user, diagnostic laboratories segment accounted for the largest share of the overall NIPT market in 2019, as the large volume of NIPT testing done at diagnostic laboratories owing to availability of the well-equipped facility and availability of trained/skilled laboratory technicians. The initiatives taken by diagnostic laboratories to provide high quality testing services is further driving the growth in this market.
This research report analyzes major geographies and provides comprehensive analysis for North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America, and the Middle East & Africa. North America commanded the largest share of the global non-invasive prenatal testing market in 2019, followed by Europe and Asia-Pacific regions. High diagnostic and treatment rate of trisomy disorders and the emergence of key organizations in the U.S. are accelerating the non-invasive prenatal testing market in the North American region.
Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5068
Key questions answered in the report-
  • Which are the high growth market segments in terms of product & solutions, method, application, end-users, and region/countries?
  • What was the historical market for non-invasive prenatal testing across the globe?
  • What are the market forecasts and estimates for the period 2019-2027?
  • What are the major drivers, restraints, opportunities, and trends in the global non-invasive prenatal testing market?
  • Who are the major players in the non-invasive prenatal testing market?
  • How is the competitive landscape and who are the market leaders in the global non-invasive prenatal testing market?
  • What are the different strategies adopted by the major players in the global non-invasive prenatal testing market?
  • What are the geographical trends and high growth regions/ countries?
Key Players
The key players operating in the global non-invasive prenatal testing market are Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), PerkinElmer, Inc. (Massachusetts), Illumina, Inc. (U.S.), Beijing Genomics Institute (China), Eurofins LifeCodexx AG (Germany), NATERA, INC. (U.S.), Igenomix SL (Spain), Laboratory Corporation of America Holdings (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), GE Healthcare (U.S.), and Yourgene Health (U.K.) among others.
Request Free Sample Report to get the short-term and long-term impact of COVID-19 on this Market https://www.meticulousresearch.com/request-sample-report/cp_id=5068
Scope of the Report:
Non-Invasive Prenatal Testing Market by Product & Solutions
  • Kits / Consumables
  • Systems
    • Nuchal Translucency Ultrasound Devices
    • Next Generation Sequencing Systems
    • Microarrays
    • Polymerase Chain Reaction Instruments
  • Software
Market by Non-Invasive Prenatal Testing Method
  • Ultrasound Screening
  • Cell-free DNA Screening
Non-Invasive Prenatal Testing Market by Application
  • Trisomy Detection
  • Microdeletions Syndrome
  • Sex Chromosomal Abnormalities
  • Other Applications
Note: Other applications include sex determination and cystic fibrosis
Non-Invasive Prenatal Testing Market by End User
  • Diagnostic Laboratories
  • Hospitals
  • Academic and Research Institutes
Non-Invasive Prenatal Testing Market by Geography
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East and Africa                       ………..Continue
Download Sample Copy of Report, published in Feb 2020, with key industry insights spread across 191 pages, with 169 market data tables, 44 fig, including all graphs and charts @:  https://www.meticulousresearch.com/download-sample-report/cp_id=5068
Browse More Report of This Category at:
Urinalysis Market by Product (Pregnancy & Fertility Test, Dipstick, Reagent, Automatic, Semi-automatic, POC Analyzer), Application (Pregnancy, Diabetes, Kidney Disease, UTI), End-user (Hospitals and Clinics, Laboratory, Home Care) – Global Forecast to 2027
Healthcare IT Market by Product (EMR, mHealth, PHM, RIS, PACS, RCM, Healthcare Analytics, Telehealth, SCM, HIE), Component (Software, Service), Delivery Mode (Web, Cloud) and End User (Hospital, Payer, Pharmacy, Ambulatory, Homecare) – Global Forecast to 2027
Healthcare Virtual Assistants Market by Product (Chatbot and Smart Speaker), Technology (Speech Recognition, Text-to-Speech, and Text Based), End User (Providers, Payers, and Other End User), and Geography–Global Forecast to 2025
Digital Diabetes Market by Product (SMBG, CGM, Smart Insulin Pump, Smart Insulin Pens, Software, Apps), End User (Home Care, Hospitals and Clinics), and Geography–Global Forecast to 2025
Contact Us:
Khushal
Meticulous Research®
Contact Sales- +1-646-781-8004
Email: sales@meticulousresearch.com
Website: https://www.meticulousresearch.com
Find us on: | LinkedIn | Twitter |

Monday, January 6, 2020

𝐍𝐨𝐧 𝐈𝐧𝐯𝐚𝐬𝐢𝐯𝐞 𝐏𝐫𝐞𝐧𝐚𝐭𝐚𝐥 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 (𝐍𝐈𝐏𝐓) 𝐌𝐚𝐫𝐤𝐞𝐭 𝟐𝟎𝟏𝟗-𝟐𝟎𝟐𝟕: 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭, 𝐌𝐞𝐭𝐡𝐨𝐝, 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧, 𝐚𝐧𝐝 𝐭𝐨𝐩 𝐤𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬

Meticulous Research®– leading global market research company published a research report titled “Non Invasive Prenatal Testing (NIPT) Market by Product (Consumables, NGS, Ultrasound, Microarray, PCR), Method (Ultrasound Screening, Cell Free DNA Test), Application (Trisomy, Sex Chromosome Abnormalities), & End User – Forecast to 2027”. 
According to this latest publication from Meticulous Research®, the Global Non-Invasive Prenatal Testing Market is expected to grow at a CAGR of 17.1% from 2019 to exceed $13.6 billion by 2027. The high growth of non-invasive prenatal testing market is mainly attributed to the high risk of chromosomal abnormalities with increasing maternal age, rise in occurrences of chromosomal aneuploidies among fetus, development of advanced and new technologies and non-invasive parenteral testing products, and improving reimbursement scenario for NIPT. Rising awareness regarding non-invasive prenatal testing and untapped market opportunity in emerging markets offer significant growth opportunities for the players operating in this market. However, strict regulatory guidelines and ethical hurdles are some of the key factors challenging the adoption of non-invasive prenatal testing products over the coming years.
Table of content
1.Introduction  
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency and Limitations
1.3.1. Currency
1.3.2. Limitations
1.4. Key Stakeholders
2.Research Methodology    
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation
3. Executive Summary    
4. Market Insights
4.1. Introduction
4.2. Drivers     
4.2.1. Increase in Progressive Maternal Age
4.2.2. Rise in Occurrences of Chromosomal Aneuploidies Among Foetus
4.2.3. Availability of Reimbursement Scenario for NIPT
4.2.4. Development of Advanced and New Technologies and Non-Invasive Parenteral Testing Products
4.3. Restraint
4.3.1. High Cost of the Non-invasive Prenatal Screening Techniques
4.4. Opportunities     
4.4.1. Rising Awareness Regarding NIPT
4.4.2. Untapped Emergence of New Market
4.5. Challenges
4.5.1. Reliability of the Tests
5. Global NIPT Market, by Product and Solution
5.1. Introduction
5.2. Consumables
5.3. Systems
5.3.1. Nuchal Translucency Ultrasound Devices
5.3.2. Next-Generation Sequencing Systems
5.3.3. Microarrays
5.3.4. Polymerase Chain Reaction Instruments
5.4. Software
5.5. Services
6. Global NIPT Market, by Method
6.1. Introduction
6.2. Ultrasound Screening
6.3. Cell-Free DNA Screening    …………Continue
Growth prospects in NIPT market
The global non-invasive prenatal testing market study presents historical market data in terms of values (2017 and 2018), estimated current data (2019), and forecasts for 2027-by product and solutions (consumables, instruments, software, services), method (ultrasound detection, biochemical screening tests, cellfree DNA in maternal plasma tests), application (trisomy, microdeletion syndrome, others), and end users. The study also evaluates industry competitors and analyzes the market at a regional and country level.
On the basis of products and solutions, the NIPT services segment is expected to grow at the fastest CAGR during the forecast period. The highest CAGR of this segment is mainly attributed to factors such as rising incidence of genetic disorders, increasing focus on prenatal screening, and government initiatives to provide prenatal testing services.
On the basis of application, trisomy segment is estimated to account for the largest share of the overall NIPT market in 2019. The large share of this segment is mainly attributed to the factors such as increasing maternal age and rising incidence of chromosomal abnormalities.
On the basis of end user, diagnostic laboratories segment is estimated to account for the largest share of the overall NIPT market in 2019, due to large volume of NIPT testing done at diagnostic laboratories owing to availability of the well-equipped facility and trained/skilled laboratory technicians. The initiatives taken by diagnostic laboratories to provide high quality testing services is driving the growth in this market.
Download sample copy of report before purchasing this report @  https://www.meticulousresearch.com/request-sample-report/cp_id=5068
This research report analyzes major geographies and provides comprehensive analysis for North America (U.S., Canada), Europe (Germany, France, the U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America, and Middle East & Africa. North America commanded the largest share of the global non-invasive prenatal testing market, followed by Europe and Asia-Pacific. High diagnostic and treatment rate of trisomy disorders and the emergence of key organizations in the U.S. are accelerating the non-invasive prenatal testing market in the North American region. However, Asia Pacific region is expected to grow at the highest CAGR during the forecast period due to developing healthcare infrastructure, rising focus of prominent players on expanding their presence in Asia, and rising awareness programs & conferences.
The key players operating in the global non-invasive prenatal testing market are Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), PerkinElmer, Inc. (U.S.), Illumina, Inc. (U.S.), Beijing Genomics Institute (China), Eurofins LifeCodexx AG (Germany), NATERA, INC. (U.S.), Igenomix SL (Spain), Laboratory Corporation of America Holdings (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), GE Healthcare (U.S.), and Yourgene Health (U.K.) among others.
Key questions answered in the report-
  • Which are the high growth market segments in terms of product & solutions, method, application, end-users, and region/countries?
  • What was the historical market for non-invasive prenatal testing across the globe?
  • What are the market forecasts and estimates for the period 2019-2027?
  • What are the major drivers, restraints, opportunities, and trends in the global non-invasive prenatal testing market?
  • Who are the major players in the non-invasive prenatal testing market?
  • How is the competitive landscape and who are the market leaders in the global non-invasive prenatal testing market?
  • What are the different strategies adopted by the major players in the global non-invasive prenatal testing market?
  • What are the geographical trends and high growth regions/ countries?
Contact Us:
Meticulous Research®
Contact Sales- +1-646-781-8004